Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.
Xie T, Lu S, He Z, Liu H, Wang J, Tang C, Yang T, Yu W, Li H, Yang Y, Yang H, Yue L, Zhou Y, Yang F, Luo Z, Li Y, Xiang H, Zhao Y, Wang J, Wang H, Long R, Kuang D, Tan W, Peng X, Li Q, Xie Z.
Xie T, et al. Among authors: wang h, wang j.
Signal Transduct Target Ther. 2022 Feb 25;7(1):61. doi: 10.1038/s41392-022-00920-4.
Signal Transduct Target Ther. 2022.
PMID: 35217639
Free PMC article.